| CTRI Number |
CTRI/2018/01/011111 [Registered on: 02/01/2018] Trial Registered Prospectively |
| Last Modified On: |
02/01/2018 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Use of education and mobile SMS reminder to increase drug intake in chronic kidney patients with cardiovascular disease |
|
Scientific Title of Study
|
Effect of behavioural intervention using education and SMS reminders on medication adherence in chronic kidney disease patients with co-existing cardiovascular disease-A randomised controlled trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pradeep T |
| Designation |
Pharmacology post graduate |
| Affiliation |
St Johns medical college |
| Address |
Room no :103
Nirmala block
St Johns medical college
Department of Pharmacology
Bangalore
Karnataka
Bangalore KARNATAKA 560034 India |
| Phone |
8220586899 |
| Fax |
|
| Email |
pradeep91t@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Denis Xavier |
| Designation |
MD Pharmacology |
| Affiliation |
St Johns medical college |
| Address |
Professor,
Department of Pharmacology,
St Johns medical college,
Koramangala,
Bangalore,
Karnataka
Bangalore KARNATAKA 560034 India |
| Phone |
9886126801 |
| Fax |
|
| Email |
denis.xavier@stjohns.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Pradeep T |
| Designation |
Pharmacology post graduate |
| Affiliation |
St Johns medical college |
| Address |
Room no :103,
Nirmala block,
St Johns medical college,
Department of Pharmacology,
Bangalore,
Karnataka
Bangalore KARNATAKA 560034 India |
| Phone |
8220586899 |
| Fax |
|
| Email |
pradeep91t@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr.Pradeep T
Pharmacology Post graduate
St Johns medical college
Bangalore
Karnataka-560034 |
|
|
Primary Sponsor
|
| Name |
Dr Pradeep T |
| Address |
room no:103
nirmala block
st Johns medical college
bangalore
karnataka |
| Type of Sponsor |
Other [self funding] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pradeep T |
St Johns medical college hospital |
Department of Nephrology
Koramangala
Bangalore
Karnataka Bangalore KARNATAKA |
8220586899
pradeep91t@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee, St. John’s National Academy of Heath Sciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
chronic kidney disease patients with coexisting cardiovascular disease, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
control group |
- The participants in these group received usual standard care with regular follow-up with the Nephrologist with regular advice about diet and medication from them. |
| Intervention |
Intervention group |
-we provide systemic education using a diary which also has pill intake records at end and also provide motivational discussion based on barriers identified for medication adherence
- we also sent one SMS reminder per week based on adherence,disease and diet |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Diagnosed chronic kidney disease stage 1 to 4 with atleast one cardiovascular disease risk factor such as diabetes mellitus, hypertenion, dyslipidaemia or etablished cardiovascular disease |
|
| ExclusionCriteria |
| Details |
1.psychiatric disorder or visual disturbance without a care taker
2.patients who are unlikely to follow up for 3 months
3.patient or care giver without mobile phones or unable to read english messages
4.critically ill patients or on dialysis
5.patients who dont know languages such as tamil, english, kannada and malayalam |
|
|
Method of Generating Random Sequence
|
Permuted block randomization, variable |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To measure adherence at the end of 3 month in both groups |
To measure adherence at the end of 3 month in both groups |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To measure clinical outcome and knowledge at the end of 1 and 3 months |
To measure clinical outcome and knowledge at the end of 1 and 3 months |
|
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
15/02/2018 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="2" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Background:The burden of chronic kidney disease is exponentially increasing. The complexity of treatment, lack of knowledge and increasing number of associated comorbidities lead on to non-adherence to treatment. Poor adherence to the treatment is a key factor that leads to progression of disease and mortality especially the cardiovascular mortality. The SMS and education based intervention is found to improve medication adherence in many diseases.There are no SMS based behavioral intervention studies to improve adherence in Chronic kidney disease with coexisting cardiovascular disease in India. we confirmed this by searching PUBMED using the following MeSH terms from years 2007 to June 2017: behavioral intervention, SMS, chronic kidney disease, chronic kidney disease and cardiovascular disease and adherence.We are therefore proposing a behavioral interventional study using education and SMS reminders to assess its effect on medication adherence among patients with co-existing CKD and CVDObjective: Among Chronic kidney disease patients with established cardiovascular disease or its risk factors visiting a tertiary care teaching hospital: Primary objective: - To assess the effect of education and SMS reminders on medication adherence at 3 months Secondary objectives: - To assess the clinical outcomes at the end of 3 months - To assess the Knowledge, Attitude and Practices (KAP) about disease at the end of 3 months in both groups Methodology: - In-patients will be identified as per selection criteria mentioned above from the relevant departments of St. Johns medical college hospital. The consultants from the respective deparments will help in indentification of cases. A written informed consent from the patient and his/her first degree relative will be taken. We random list the days of recruitment from the in-patient wards of relevant departments based on computer generated random list.Then we will note down the baseline demographic data, KAP, lab parameters and medication adherence using morisky adherence measuring scale and pill count method. - Then we randomize the patient using a variable block randomization in a 1:1 allocation ratio to either intervention or control group - Intervention group received education using a booklet at the time of discharge which has pill intake records at the end. They will also been given motivational discussion based on barriers identified at baseline and at every follow-up. The patients in intervention will also been sent one SMS in week based on 4 domains. During the 1st month follow-up either personal or through mobile, we ask about message delivery, give motivational discussion and also we measure adherence. During the final follow-up at 3rd month we measure KAP, clinical status and medication adherence - Control group received usual standard care with routine follow-up with the physician and regular advice about the diet and medication by the physician. During the 1st month follow-up either personal or through mobile, we ask about message delivery and also we measure adherence. During the final follow-up at 3rd month we measure KAP, clinical status and medication adherence.
Statistical methods: -Data entry will be done using Epi Info version 7.2. All statistical analyses will be performed using Statistics Package for the Social Sciences (SPSS) version 21. -Demographic and base line variables such as age, gender, socio-economic status will be analysed using descriptive statistics. -Continuous variables such as glucose levels, HbA1C, BP, lipid profile and serum creatinine levels will be summarized using mean (± SD) and analysed using t-test/ANOVA. -Clinical / lab parameters between 2 groups will be analysed using Chi-square or student t-test. -Difference of change in adherence between the two groups from baseline will be analysed using chi squared tests and determinants of adherence explored using multivariate analysis. A p value <0.05 will be considered significant for all tests. |